Share chart Astria Therapeutics, Inc.
Extended chart
Simple chart
About Astria Therapeutics, Inc.
Astria Therapeutics, Inc., биофармацевтическая компания, занимается открытием, разработкой и коммерциализацией терапевтических средств для лечения редких и нишевых аллергических и иммунологических заболеваний в Соединенных Штатах. Его ведущим продуктом-кандидатом является STAR-0215, моноклональное антитело-ингибитор калликреина плазмы, которое находится на стадии клинической разработки для лечения наследственного ангионевротического отека. Компания ранее называлась Catabasis Pharmaceuticals, Inc. и сменила название на Astria Therapeutics, Inc. в сентябре 2021 года. Astria Therapeutics, Inc. more details| IPO date | 2015-06-25 |
|---|---|
| ISIN | US04635X1028 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.astriatx.com |
| Цена ао | 6.64 |
| Change price per day: | 0% (6.64) |
|---|---|
| Change price per week: | +7.27% (6.19) |
| Change price per month: | -5.01% (6.99) |
| Change price per 3 month: | -30.25% (9.52) |
| Change price per half year: | -40.87% (11.23) |
| Change price per year: | -57.05% (15.46) |
| Change price per 3 year: | -1.34% (6.73) |
| Change price per 5 year: | +22.28% (5.43) |
| Change price per 10 year: | 0% (6.64) |
| Change price per year to date: | -30.54% (9.56) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| FMR, LLC | 2565052 | 5.79 |
| Vivo Capital, LLC | 2482727 | 5.6 |
| Perceptive Advisors LLC | 2189462 | 4.94 |
| Fairmount Funds Management LLC | 1901397 | 4.29 |
| Blackrock Inc. | 1688836 | 3.81 |
| Vanguard Group Inc | 1509921 | 3.41 |
| Driehaus Capital Management, LLC | 1454204 | 3.28 |
| Altium Capital Management, LP | 1347088 | 3.04 |
| Saturn V Capital Management LLC | 1219093 | 2.75 |
| Deep Track Capital, LP | 1037873 | 2.34 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.14457 | 17.09 | 1.54048 |
iShares Russell 2000 Growth ETF
|
0.03497 | 38.04 | 0.6026 |
| iShares Morningstar Small-Cap Growth ETF | 0.01779 | 33.63 | 0.72598 |
| iShares Morningstar Small-Cap Growth ETF | 0.01779 | 587.89 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.00881 | 30.1 | 1.60498 |
| iShares Morningstar Small-Cap ETF | 0.00881 | 391.25 | 1.60498 |
| iShares Russell 3000 ETF | 0.00097 | 24.83 | 1.43482 |
| 0.03 | 160.4 | 1.18 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Jill C. Milne Ph.D. | Co-Founder, CEO, President & Director | 928.52k | 1968 (57 years) |
| Mr. Benjamin S. Harshbarger J.D. | Chief Legal Officer | 621.91k | 1969 (56 years) |
| Ms. Keri McGrail | Senior Vice President of Human Resources | N/A | |
| Ms. Andrea L. Matthews | Chief Business Officer | N/A | 1982 (43 years) |
| Mr. Andrew A. Komjathy | Chief Commercial Officer | N/A | 1963 (62 years) |
| Dr. Christopher J. Morabito M.D. | Chief Medical Officer | N/A | 1970 (55 years) |
| Mr. John Ruesch | Senior Vice President of Pharmaceutical Sciences & Technical Operations | N/A | |
| Mr. Noah C. Clauser CPA | CFO & Treasurer | 508.79k | 1974 (51 year) |
Address: United States, Boston. MA, 75 State Street - open in Google maps, open in Yandex maps
Website: https://www.astriatx.com
Website: https://www.astriatx.com
